MDxHealth SA MDXH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $0.16
- Day Range
- $0.16–0.17
- 52-Week Range
- $0.14–4.66
- Bid/Ask
- $0.17 / $0.17
- Shares Outstanding
- 95.42M
- Market Cap
- $16.36M
- Volume/Avg
- 650,310 / 6M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.07
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 364
- Website
- https://www.mdxhealth.com
Valuation
Metric | MDXH |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.07 |
Price/Cash Flow | — |
Price/Earnings
MDXH
Financial Strength
Metric | MDXH |
|---|---|
Quick Ratio | 0.91 |
Current Ratio | 1.15 |
Interest Coverage | −3.50 |
Quick Ratio
MDXH
Profitability
Metric | MDXH |
|---|---|
Return on Assets (Normalized) | −16.74% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −24.10% |
Return on Assets
MDXH
Diagnostics & Research Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc TMO | LOCK|xT?!W!^f | LOCK|J@$ | $257B | |||
| Danaher Corp DHR | LOCK|&Nz%@$K | LOCK|@LN | $162B | |||
| IDEXX Laboratories Inc IDXX | LOCK|^w<<@hz | LOCK|%hb | $53B | |||
| Agilent Technologies Inc A | LOCK|SHsfDG#x | LOCK|L& | $49B | |||
| Waters Corp WAT | LOCK|^&%>cL% | LOCK|bx | $45B | |||
| IQVIA Holdings Inc IQV | LOCK|mHRdB%! | LOCK|x?MT? | $45B | |||
| Mettler-Toledo International Inc MTD | LOCK|$Yz^kjp | LOCK|JJ@^ | $34B | |||
| Illumina Inc ILMN | LOCK|X^l@C?% | LOCK|<dVZ | $32B | |||
| Labcorp Holdings Inc LH | LOCK|z#r&RSw | LOCK|jflrM | $30B | |||
| Quest Diagnostics Inc DGX | LOCK|$$$XVg | LOCK|xn^p | $28B |
United States